Timing and Clinical Presentation of Carbon Monoxide Poisoning

Acute High‑Concentration Exposure

• Lethal effects occur within ≈5 minutes at 5 000 ppm, ≈30 minutes at 3 200 ppm, and ≈45 minutes at 2 100 ppm of carbon monoxide. 1, 2, 3, 4
• “Lights‑out collapse” – sudden unconsciousness without prodromal symptoms – can result from direct central nervous system toxicity independent of carboxyhemoglobin (COHb) levels. 1, 2

Symptom Progression According to COHb Levels

Correlation Between COHb Levels and Clinical Presentation

• An analysis of 1 323 patients showed no consistent correlation between initial COHb concentration and the severity of clinical presentation; symptom severity is a more reliable guide for management. 1, 2
• Chronic smokers often have a baseline COHb of 5–12 %, which can mask mild poisoning and delay recognition. 1, 5

Chronic Low‑Level Exposure

• Repeated low‑level exposure (e.g., in poorly ventilated homes) leads to gradual onset of persistent headache, dizziness, nausea, memory problems, and fatigue over days to weeks. 1, 2, 6
• Such exposure can exacerbate underlying cardiovascular disease. 1, 6

Delayed Neurological Sequelae (DNS)

• DNS develop 3–240 days after the initial exposure and affect 10–30 % of survivors; the most common onset window is 27–270 days post‑exposure. 1, 2, 4
• Reported delayed manifestations include:
  
  • Cognitive decline and memory loss 1, 2
  • Personality changes and psychiatric disturbances 1, 4
  • Movement disorders and parkinsonism 1, 2
  • Seizures and motor dysfunction 2, 4
  • Urinary incontinence 2
• A lucid interval may precede DNS, during which patients appear fully recovered; this biphasic pattern is driven by secondary inflammation, apoptosis, and immune‑mediated demyelination rather than the initial hypoxic injury. 1, 2, 4

Special Populations – Pregnancy

• Pregnant women can remain asymptomatic while the fetus accumulates CO and sustains injury; therefore, aggressive treatment is recommended regardless of maternal symptomatology. 1, 2, 8

Oxygen Therapy and COHb Half‑Life

• Immediate recognition and prompt oxygen therapy (normobaric or hyperbaric) are critical to prevent both acute mortality and delayed neurological injury. 1, 3, 4

Management of Suspected Carbon Monoxide Poisoning from Forklift Exposure

Immediate Pre‑hospital and Emergency Department Oxygen Therapy

• Administer 100 % normobaric oxygen immediately via a tight‑fitting non‑rebreather mask at 8–12 L/min to any patient with suspected CO poisoning, without awaiting carboxyhemoglobin results. 10
• High‑flow oxygen shortens COHb half‑life from ≈ 320 min on room air to 74–90 min, accelerating CO displacement and tissue re‑oxygenation. 10
• Pulse‑oximetry cannot differentiate COHb from oxyhemoglobin; SpO₂ values are therefore falsely normal and should not guide therapy. 10

Indications for Hyperbaric Oxygen Therapy (HBOT)

• Loss of consciousness (syncope) is the single strongest indication for HBOT in CO poisoning. 10
• Altered mental status (e.g., dysgeusia) also warrants HBOT because it suggests neurological involvement. 10
• HBOT should be initiated as early as possible, ideally within 200 minutes of exposure; treatment ≤ 6 hours is acceptable, but outcomes are best when the ≤ 200‑minute window is met. 10

HBOT Protocol

• The typical regimen is 2.2–2.8 ATA for 60–120 minutes per session. 10
• A second HBOT session may be considered if the initial response is inadequate; evidence supporting more than two sessions is limited. 10

Supportive Care and Hemodynamic Management

• Obtain early intravenous access and treat hypotension with isotonic crystalloids; add vasopressors if needed. 10
• Advise strict physical rest because exertion raises oxygen demand and can worsen hypoxia. 10
• If seizures occur, control them promptly with benzodiazepines. 10

Continuous Monitoring

• Continuously monitor heart rate, blood pressure, respiratory rate, and level of consciousness. 10
• Vigilantly watch for signs of cerebral edema (e.g., bradycardia, respiratory depression, unsteady gait, persistent vomiting, increased muscle tone, visual disturbances, disorientation, pathological reflexes, or seizures). 10

Laboratory and Cardiac Assessment

• Obtain a COHb level, but do not delay oxygen therapy while awaiting the result. 11
• Perform ECG and measure cardiac biomarkers (troponin) to evaluate for myocardial ischemia, which constitutes an additional indication for HBOT. 10
• Measure serum lactate and arterial pH; if pH < 7.2 and lactate > 10 mmol/L persist after ≥ 30 minutes of 100 % oxygen, consider co‑existing cyanide poisoning. 12

Duration of Normobaric Oxygen When HBOT Is Unavailable

• Continue 100 % normobaric oxygen until COHb falls below 3 % and symptoms have resolved, which typically requires at least 6 hours of therapy. 11
• If the patient has tolerated high‑flow oxygen for ~6 hours and feels well, repeat COHb measurement is unnecessary. 11

Source Control and Discharge Planning

• Prior to discharge, identify and eliminate the CO source; a workplace safety evaluation is mandatory to prevent re‑exposure. 11